1. Introduction {#sec1-molecules-20-19890}
===============

Endophytic fungi that reside in plants are promising sources of a variety of bioactive metabolites. These metabolites are usually structurally novel and display important biological or pharmaceutical properties, such as antimicrobial or cytotoxic activities \[[@B1-molecules-20-19890],[@B2-molecules-20-19890],[@B3-molecules-20-19890]\]. *Smilax glabra* is a common wild plant and has been used in folk medicine for the treatment of brucellosis, syphilis, acute and chronic nephritis, and metal poisoning \[[@B4-molecules-20-19890],[@B5-molecules-20-19890],[@B6-molecules-20-19890],[@B7-molecules-20-19890]\]. In this study, the endophytic fungal strain *Guignardia mangiferae* A348 was isolated from leaves of *S. glabra* collected in Luofu Mountain Natural Reservation of China. Previous chemical investigations of the genus *guignardia* yielded several bioactive secondary metabolites, including meroterpenoids, spirodioxynaphthalenes, vermistatin and penicillide derivatives \[[@B8-molecules-20-19890],[@B9-molecules-20-19890],[@B10-molecules-20-19890],[@B11-molecules-20-19890],[@B12-molecules-20-19890]\]. As part of an ongoing program aimed at exploring the secondary metabolites of fungi obtained from medicinal plants, we previously isolated several sterols, and aliphatics from the strain *G. mangiferae* A348 derived from *Smilax glabra* \[[@B13-molecules-20-19890]\]. Continued chemical investigation of laboratory cultures of *G. mangiferae* A348 resulted in the isolation of seven meroterpenoids ([Figure 1](#molecules-20-19890-f001){ref-type="fig"}), including four new analogues, guignardones P--S (**1**--**4**). Compounds **1**--**7** were evaluated for their cytotoxicities against SF-268, MCF-7, and NCI-H460 cell lines. Herein, the isolation, structure elucidation, and the inhibitory activities of these meroterpenoids are described.

![The chemical structures of compounds **1**--**7**.](molecules-20-19890-g001){#molecules-20-19890-f001}

2. Results and Discussion {#sec2-molecules-20-19890}
=========================

The fermentation broth of the endophytic fungal strain *G. mangiferae* A348 was extracted with EtOAc and then concentrated under reduced pressure to give an extract. The EtOAc extract was subjected to various column chromatography protocols to afford compounds **1**--**7**. These new structures were identified by spectroscopic analyses and physicochemical properties, while the known analogues were identified as guignardone A (**5**) \[[@B14-molecules-20-19890]\], guignardone B (**6**) \[[@B14-molecules-20-19890]\], and guignardone I (**7**) \[[@B15-molecules-20-19890]\] by comparison of their spectroscopic data and specific rotations with those in the literature.

2.1. Identification of New Compounds {#sec2dot1-molecules-20-19890}
------------------------------------

Compound **1**, a colorless crystal, had the molecular formula C~18~H~26~O~5~, as established by HREIMS, corresponding to six degrees of unsaturation. The ^1^H-NMR spectrum ([Table 1](#molecules-20-19890-t001){ref-type="table"}) exhibited signals for four methyls \[δ~H~ 3.08 (3H, s, H~3~-18, methoxy group), 1.29 (3H, s, H~3~-11), 1.09 (3H, s, H~3~-16), and 1.08 (3H, s, H~3~-17)\], three oxymethine protons \[δ~H~ 4.55 (1H, d, *J* = 5.4 Hz, H-4), 3.79 (1H, d, *J* = 7.9 Hz, H-7a), and 3.48 (1H, d, *J* = 7.9 Hz, H-7b)\], and a series of aliphatic methylene multiplets. The ^13^C-NMR spectrum, in combination with HSQC experiment, resolved 18 carbon resonances attributable to a carbonyl (δ~C~ 198.6, C-1), a tetrasubstituted double bond \[δ~C~ 173.7 (C-3) and 102.8 (C-2)\], four methyls \[δ~C~ 48.9 (C-18), 23.3 (C-17), 22.9 (C-11), and 21.9 (C-16)\], five sp^3^ methylenes \[δ~C~ 70.5 (C-7, bearing heteroatom), 43.9 (C-5), 38.0 (C-12), 24.4 (C-13), and 17.6 (C-8)\], three sp^3^ methines \[δ~C~ 78.4 (C-4, bearing heteroatom), 41.1 (C-9), and 48.3 (C-14)\], and three sp^3^ quaternary carbons \[81.6 (C-6), 90.7 (C-10), 76.7 (C-15)\]). As two of the six degrees of unsaturation were accounted for by a carbonyl group, and a double bond, the remaining four degrees of unsaturation required that **1** was tetracyclic. The above mentioned information was similar to that of the known meroterpene, guignardone B (**6**), a metabolite co-isolated in the current study, except for the presence of a methoxy group in **1**. HMBC correlations from H~3~-17, H~3~-16 ([Figure 2](#molecules-20-19890-f002){ref-type="fig"}), and the methoxy group to a 4 ppm downfield-shifted carbon C-15 (δ~C~ 76.7) revealed that the methoxy group was located at C-15.

Detailed 2D analyses (HSQC, ^1^H-^1^H COSY, and HMBC) supported the planar structure of **1** as depicted. Compound **1** was further confirmed by its X-ray diffraction analysis ([Figure 3](#molecules-20-19890-f003){ref-type="fig"}), which also established its relative configuration. Thus, the structure of **1** was established and given the trivial name guignardone P.

molecules-20-19890-t001_Table 1

###### 

^1^H-NMR data of **1**−**4** in CDCl~3~ at 500 MHz (*J* in Hz, δ in ppm).

  Position               1                      2                      3                     4
  ---------------------- ---------------------- ---------------------- --------------------- ----------------------
  H-4                    4.55, d (5.4)          4.58, d (5.4)          4.27, m               4.31, t (5.4)
  H-5                    2.45, dd (10.7, 5.5)   2.44, dd (10.7, 5.5)   2.41, m               2.43, m
  2.02, d (10.7)         2.04, d (10.7)         2.24, m                2.19, m               
  H-6                                                                  3.72, dd (7.5, 3.8)   3.73 dd (7.5, 3.8)
  H-7                    3.79, d (7.9)          3.80, d (7.9)          3.49, s               3.49, s
  3.48, d(7.9)           3.51, d (7.9)                                                       
  H-8                    2.66, dd (17.0, 1.2)   2.63, dd (17.2, 7.2)   2.66, d (17.2)        2.64, dd (17.2, 7.2)
  2.20, dd (17.0, 6.1)   1.88, m                2.20, m                1.85, m               
  H-9                    2.04, m                2.39, t (8.3)          2.04, m               2.47, m
  H-11                   1.29, s                1.35, s                1.33, s               1.39, s
  H-12                   1.98, m                1.85, m                2.01, m               1.89, m
  1.62, m                1.81, m                1.60, m                1.80, m               
  H-13                   1.72, m                2.34, m                1.72, m               2.32, m
  1.52, m                2.21, m                1.60, m                2.24, m               
  H-14                   1.71, m                                       1.74, m               
  H-16                   1.09, s                1.69, s                1.12, s               1.71, s
  H-17                   1.08, s                1.57, s                1.12, s               1.59, s
  H-18                   3.08, s                                       3.12, s               
  OH                     4.26, brs              4.24, brs              3.24, d (7.2)         

![Key ^1^H-^1^H COSY (![](molecules-20-19890-i001.jpg)), HMBC (![](molecules-20-19890-i002.jpg)), and NOE (![](molecules-20-19890-i003.jpg)) correlations of compounds **1**--**4**.](molecules-20-19890-g002){#molecules-20-19890-f002}

![ORTEP diagram of compound **1**.](molecules-20-19890-g003){#molecules-20-19890-f003}

Compound **2** displayed a molecular ion at *m*/*z* 313.1392 \[M + Na\]^+^, consistent with a molecular formula of C~17~H~22~O~4~ as established by HRESIMS, 32 mass units less than that of **1**. The ^1^H- and ^13^C-NMR data of **2** ([Table 1](#molecules-20-19890-t001){ref-type="table"} and [Table 2](#molecules-20-19890-t002){ref-type="table"}) were very similar to those of **5**, implying that **2** was a tricycloalternarene. The structural differences between **2** and **5** were attributed to the different locations of the double bonds at C-14, as the HMBC correlations from H~3~-16 and H~3~-17 to C-14 in **2** revealed that the double bond was located at C-14 and C-15. Detailed 2D analyses (HSQC, ^1^H-^1^H COSY, and HMBC) revealed the planar structure of **2** as depicted ([Figure 3](#molecules-20-19890-f003){ref-type="fig"}). The relative configuration of **2** was assigned to be the same as that of **1** by comparing their 1D NMR data and by analyzing its NOESY data. In particular, the NOESY correlations of H-9/H~3~-11, and H~3~-11/H-4 indicated that H-4, H-9, H~3~-11 and OH-6 were co-facial and arbitrarily assigned in α-oriented. Thus, the structure of **2** was established as depicted in [Figure 1](#molecules-20-19890-f001){ref-type="fig"} and was given the trivial name guignardone Q.

molecules-20-19890-t002_Table 2

###### 

^13^C-NMR data of **1**−**4** in CDCl~3~ at 125 MHz (*J* in Hz, δ in ppm).

  Position   1       2       3       4
  ---------- ------- ------- ------- -------
  1          198.6   198.1   194.9   194.5
  2          102.8   104.5   105.7   107.2
  3          173.7   172.2   168.3   168.0
  4          78.4    78.2    65.8    66.0
  5          43.9    44.0    34.6    34.7
  6          81.6    81.6    79.1    78.9
  7          70.5    70.4    58.4    58.3
  8          17.6    19.6    18.3    19.8
  9          41.1    41.4    41.1    41.9
  10         90.7    86.5    89.0    85.7
  11         22.9    25.4    22.3    25.3
  12         38.0    34.7    38.2    36.4
  13         24.4    25.2    24.4    25.3
  14         48.3    133.8   49.2    134.0
  15         76.7    125.1   76.8    125.2
  16         21.9    20.3    22.0    20.5
  17         23.3    20.9    23.0    21.0
  18         48.9            49.0    

Compound **3** was obtained as a white powder with a molecular formula C~18~H~28~O~5~ as established by HRESIMS at *m*/*z* 347.1814 \[M + Na\]^+^ (calcd 347.1834). The ^1^H-NMR spectrum of **3** displayed signals for five methyls (including two methoxy groups), two oxymethine protons, and a series of aliphatic methylene multiplets. The ^13^C-NMR spectrum, in combination with HSQC experiment, resolved 18 carbon resonances attributable to a carbonyl, a tetrasubstituted double bond, five methyls (including two methoxy group at δ~C~ 49.0 and 58.4), four sp^3^ methylene, four sp^3^ methines (two bearing heteroatom), and two sp^3^ quaternary carbons bearing oxygen atom. The aforementioned data were very similar to those of the co-isolated known meroterpene, guignardone I (**7**), except for the presence of an extra methoxyl at C-15 in **3**. Detailed 2D NMR analyses of **3** located the methoxyl at C-15 \[HMBC correlation from H3-18 (δ~H~ 3.12) to C-15 (δ~C~ 76.8)\]. The relative configuration of **3** was determined to be the same as **7** based on comparison of their ^1^H-^1^H coupling constants and chemical shifts. Thus, compound **3** was given the trivial name guignardone R.

HRESI(+)MS analysis of **4** revealed a highest mass *m*/*z* ion cluster consistent with a molecular formula (C~17~H~24~O~4~), requiring six double bond equivalents (DBE). Comparison of the NMR spectroscopic data for **4** with those for **3** revealed common subunits C-1 to C-8 and C-10 to C-12 accounting for five DBE, with the significant differences attributed to the presence of the non-conjugated double bond (δ~C~ 134.0 and 125.2; C-14 and C-15) in **4** instead of the methine (C-14) and oxygenated quaternary carbon (δ~C~ 76.8) in **3**. The gross structure of **4** was fully determined by the HMBC spectrum ([Figure 3](#molecules-20-19890-f003){ref-type="fig"}) and the stereochemistry was determined to be the same as that of **3** on the basis of analysis of its ^1^H-^1^H coupling constant and NOESY data. Thus, compound **4** was deduced as depicted and named guignardone S.

2.2. Cytotoxicity Assay {#sec2dot2-molecules-20-19890}
-----------------------

The *in vitro* cytotoxicities of compounds **1**--**7** were evaluated against three cancer cell lines, including SF268, MCF7, and NCI-H460. Compounds **2** and **4** exhibited weak growth inhibitions of cell proliferation against the cancer cell line MCF-7 with IC~50~ values of 83.7 and 92.1 μM, respectively.

3. Materials and Methods {#sec3-molecules-20-19890}
========================

3.1. General Experimental Procedures {#sec3dot1-molecules-20-19890}
------------------------------------

NMR spectra were recorded on a Bruker AVANCE 500 spectrometer (Bruker Corporation, Fremont, CA, USA) and referenced to the signals of tetramethylsilane as an internal standard. HREIMS was performed with an API QSTAR time-of-flight spectrometer (Thermo Fisher Scientific, Bremen, Germany) and HR-ESITOFMS were recorded on a Waters Acquity UPLC-Q-TOF Micro focus spectrometer (Waters Corp., Milford, MA, USA). X-ray structure determination: Rigaku R-AXIS SPIDER (Rigaku Corporation, Tokyo, Japan). UV spectra were recorded on a Biochrom Ultrospec 6300 pro UV-Visible spectrophotometer (GE Healthcare, London, UK). IR spectra were measured on a Perkin-Elmer Spectrum 100. A Shimadzu LC-20 AT (Shimadzu Corporation, Kyoto, Japan) equipped with an SPD-M20A PDA detector (Shimadzu Corporation) was used for HPLC, a YMC-pack ODS-A column (250 × 10 mm, 5 µm, 12 nm) was used for semipreparative HPLC separation and a YMC-pack ODS-A column (250 × 20 mm, 5 µm, 12 nm) was used for preparative HPLC separation. Column chromatography (CC, 250 × 40 mm): commercial silica gel (SiO~2~; 200--300 mesh; Qingdao Marine Chemical Plant, Qingdao, China). All solvents used were of analytical grade (Guangzhou Chemical Reagents Company, Ltd., Guangzhou, Guangdong, China).

3.2. Fungal Material {#sec3dot2-molecules-20-19890}
--------------------

The endophytic fungal strain A348 was isolated from *Smilax glabra*, which was collected in Luofu Mountain Natural Reservation, Guangdong Province, China, in 17 November 2008. The isolated strain was identified as *Guignardia mangiferae* based on a morphological study and sequence analysis of rDNA ITS (internal transcribed spacer) with 99.8% similarity to the strain of *Guignardia mangiferae* ymy-11 (Accession No. EU677819) \[[@B13-molecules-20-19890]\]. The strain is preserved at the State Key Laboratory of Applied Microbiology Southern China, Guangdong Institute of Microbiology.

3.3. Extraction and Isolation {#sec3dot3-molecules-20-19890}
-----------------------------

The endophytic strain of *G. mangiferae* A348 was cultured in potato dextrose (PD) liquid medium, consisting of potato starch 20%, dextrose 2%, KH~2~PO~4~ 0.3%, MgSO~4~ 0.15%, Vitamin B1 10 mg/L. The cultivation was carried out at 28 °C with an agitation speed of 130 r/m for 7 days. The culture (100 L) was filtered to give the broth and mycelia. The broth was partitioned sequentially with EtOAc (3 × 300 mL) to yield a dark brown oily residue (13.8 g), which was subjected to column chromatography on silica gel using *n*-hexane as the first eluent and then acetone of increasing polarity to give six fractions (F1−F6). F3 (1397 mg) was purified on a preparative reversed-phase (RP) HPLC system equipped with a YMC column (MeOH/H~2~O, 50:50→100:0, 5 mL/min) to give nine subfractions (F3.1−F3.9). Subfraction F3.5 (43 mg) was purified on a semi-preparative reversed-phase RP-HPLC equipped with a YMC column (MeOH/H~2~O, 80:20, 3 mL/min) to give **7** (15.9 mg). Subfraction F3.6 (51 mg) was separated by RP-HPLC (YMC column, MeCN/H~2~O, 70:30, 3 mL/min) to yield **1** (6.2 mg), **3** (4.5 mg), and **6** (7.3 mg). Subfraction F3.7 (75 mg) was purified on a preparative RP-HPLC system equipped with a YMC column (MeCN/H~2~O, 80:20, 5 mL/min) to give **2** (3.3 mg), **4** (5.8 mg), and **5** (6.8 mg).

3.4. Spectroscopic Data {#sec3dot4-molecules-20-19890}
-----------------------

Guignardone P (**1**): colorless crystal (MeOH/H~2~O); m.p. 159--160 °C; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = 50 (*c* 0.1, MeOH); UV (MeOH) λ~max~ (log ε) 265 (3.41) nm; IR (KBr) ν~max~ = 3450, 2971, 2943, 2886, 1658, 1619, 1451, 1380, 1303, 1251, 1173, 1117, 1023 cm^−1^; HREIMS *m*/*z* 322.1778 (calcd for C~18~H~26~O~5~, 322.1780), composition for C~18~H~26~O~5~; ^1^H and ^13^C-NMR data, see [Table 1](#molecules-20-19890-t001){ref-type="table"} and [Table 2](#molecules-20-19890-t002){ref-type="table"}.

*Guignardone* *Q* (**2**): white, amorphous powder; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = 39 (*c* 0.1, MeOH); UV (MeOH) λ~max~ (log ε) 265 (5.49) nm; IR (KBr) ν~max~ = 3494, 2928, 2856, 1741, 1653, 1617, 1460, 1382, 1281, 1248, 1077 cm^−1^; HRESIMS \[M + Na\]^+^ *m*/*z* 313.1392 (calcd for C~17~H~22~O~4~Na \[M + Na\]^+^, 313.1416); ^1^H- and ^13^C-NMR data, see [Table 1](#molecules-20-19890-t001){ref-type="table"} and [Table 2](#molecules-20-19890-t002){ref-type="table"}.

*Guignardone* *R* (**3**): white, amorphous powder; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = −25 (*c* 0.1, MeOH); UV (MeOH) λ~max~ (log ε) 265 (2.79) nm; IR (KBr) ν~max~ = 3377, 2928, 2855, 1738, 1661, 1615, 1459, 1384, 1284, 1250, 1168, 1076, 1027 cm^−1^; HRESIMS \[M + Na\]^+^ *m*/*z* 347.1814 (calcd for C~18~H~28~O~5~Na \[M + Na\]^+^, 347.1834); ^1^H- and ^13^C-NMR data, see [Table 1](#molecules-20-19890-t001){ref-type="table"} and [Table 2](#molecules-20-19890-t002){ref-type="table"}.

*Guignardone* *S* (**4**): colorless oil; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = −17 (*c* 0.1, MeOH); UV (MeOH) λ~max~ (log ε) 262 (2.87) nm; IR (KBr) ν~max~ = 3430, 2930, 2855, 1737, 1617, 1452, 1363, 1246, 1078, 1027 cm^−1^; HRESIMS \[M + Na\]^+^ *m*/*z* 315.1530 (calcd for C~17~H~24~O~4~Na \[M + Na\]^+^, 315.1572); ^1^H- and ^13^C-NMR data, see [Table 1](#molecules-20-19890-t001){ref-type="table"} and [Table 2](#molecules-20-19890-t002){ref-type="table"}.

3.5. X-ray Crystallographic Data {#sec3dot5-molecules-20-19890}
--------------------------------

X-ray crystallographic study of Guignardone P (**1**): C~36~H~51~O~10~, M = 643.77 g/mol, orthorhombic, 0.293 × 0.138 × 0.098 mm^3^, space group P2~1~ (no. 4), *a* = 11.709 (2) Å, *b* = 10.027(2) Å, *c* = 14.378(3) Å, *α* = γ = 90 °, β = 92.49(3) °, V = 1686.5(6) Å^3^, Z = 2, D~c~ = 1.268 g·cm^−3^, F(000) = 694.0, Xcalibur, Onyx, Nova, Mo K*α* radiation, λ = 0.71073 Å, T = 293 K, 5.98° ≤ 2θ ≤ 54.96°, 16,119 reflections collected, 7576 unique (R~int~ = 0.0662). Final GooF = 1.071, R~1~ = 0.0857, wR~2~ = 0.2459, R indices based on 7576 reflections with *I* \> 2sigma(I) (refinement on *F*^2^), 424 parameters, 42 restraint. Lp and absorption corrections applied, m = 0.091 mm^−1^. Flack parameter = 0.00 (10). Crystallographic data for the structure of **1** have been deposited in the Cambridge Crystallographic Data Centre with the deposition number CCDC 1431464. These data can be obtained free of charge via <http://www.ccdc.cam.ac.uk/conts/retrieving.html> (or from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44-1223-336033; E-Mail: <deposit@ccdc.cam.ac.uk>).

3.6. Cytotoxicity Assay {#sec3dot6-molecules-20-19890}
-----------------------

The cell growth inhibitory activities of compounds **1**--**7** against human cancer cell lines SF-268, MCF-7, and NCI-H460, were tested using the previously published methods \[[@B16-molecules-20-19890]\].

4. Conclusions {#sec4-molecules-20-19890}
==============

There are increasing examples of tricycloalternarenes (TCAs) in the literature and most of them were isolated from the endophytic fungus derived from plant \[[@B15-molecules-20-19890],[@B17-molecules-20-19890]\]. The genus *Guignardia* is a rich source of TCAs such as guignardones \[[@B18-molecules-20-19890],[@B19-molecules-20-19890]\]. In our continuing investigation on the chemical constituents of endophytic fungus derived from the medicinal plant, four new meroterpenoids and three known analogues have been isolated from the endophytic fungus *Guignardia mangiferae* A348 derived from the medicinal plant *Smilax glabra*. The structures were determined by combined spectroscopic analysis and single crystal X-ray diffraction. All the isolates were evaluated for *in vitro* cytotoxicity against SF-268, MCF-7, and NCI-H460 cell lines, and both **2** and **4** exhibited weak inhibitory activities against MCF-7 cell line. Recently, guignardone B (**6**) and its analogues were reported to possess moderate inhibition of *Candida albicans* growth \[[@B12-molecules-20-19890]\]. In this study, these new compounds not only enrich the chemical variety of meroterpenoids, but also may be important for the antifungal activities.
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**Sample Availability:** Samples of the compounds **1**--**7** are available from the authors.

###### 

Click here for additional data file.

The ^1^H- and ^13^C-NMR data of **1**--**7**, HR-ESI-MS, 2D-NMR spectra of compounds **1**--**4** (Figures S1--S34) can be accessed at: <http://www.mdpi.com/1420-3049/20/12/19890/s1>.
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